Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 54,864

Document Document Title
WO/2023/065460A1
A Streptococcus thermophilus JMCC0033 and the use thereof. The strain is isolated and screened from traditional fermented milk in Inner Mongolia, and is preserved in China General Microbiological Culture Collection Center, No.3, courtyar...  
WO/2023/060509A1
Process for manufacturing a food product based on the inoculation of a food product with stable lactic acid bacteria able to maintain viability and to slightly decrease pH when stored at ambient temperature in combination with erythritol...  
WO/2023/062328A1
The present application relates to a method for producing a dry mixture of at least one yeast and/or one yeast derivative and of at least one bacteriophage, said mixture being in the form of solid entities, each solid entity consisting o...  
WO/2023/061100A1
Provided are an inactivated bacteroides fragilis powder and a preparation method therefor. The inactivated bacterial powder comprises inactivated bacteroides fragilis. The thallus of inactivated bacteroides fragilis comprises a complete ...  
WO/2023/060589A1
Provided in the present disclosure is a method for integrating one or more exogenous nucleotide sequences into a host cell genome of a mammal. The method comprises integrating the one or more exogenous nucleotide sequences into the host ...  
WO/2023/060671A1
A traditional Chinese medicine polysaccharide feed additive, and a preparation method therefor and the use thereof. The additive consists of the following components in parts by weight: 5-10 parts of lactoferrin, 3-5 parts of medium-chai...  
WO/2023/061098A1
Provided is a bacteria combination of yeast and lactic acid bacteria, comprising yeast and lactic acid bacteria. The yeast comprises Candida ethanolica B-JJ1. The lactic acid bacteria comprise at least one of Lactobacillus buchneri B-JR1...  
WO/2023/061154A1
Provided in the present invention is the use of Bacteroides fragilis in the prevention and treatment of cancer treatment-induced diarrhea. Specifically, provided is the use of Bacteroides fragilis in cancer treatment-induced diarrhea. In...  
WO/2023/056891A1
The present invention provides an engineering yeast strain for producing hyaluronidase at high yield. The engineering yeast strain is obtained by respectively integrating a hyaluronidase gene as represented by SEQ ID NO.1 into any two si...  
WO/2023/056962A1
The present invention relates to the use of Clostridium ghonii in combination with pembrolizumab in cancer therapy. It is found for the first time in the present invention that Clostridium ghonii in combination with pembrolizumab can imp...  
WO/2023/057799A1
Provided herein is a kit including at least one of five primer sets for use in the detection of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Also provided herein is a method for the detection of the presence of SARS-CoV-2...  
WO/2023/058801A1
The present invention provides a composition which comprises at least one selected from a group consisting of a Lactobacillus acidophilus KBL402 strain with accession number KCTC 14640BP or a Lactobacillus acidophilus KBL409 strain with ...  
WO/2023/056699A1
Disclosed are a genetically engineered strain capable of producing L-alanine, a construction method therefor, and an application thereof. A genetically engineered strain capable of efficiently producing alanine at a high temperature of 4...  
WO/2023/056700A1
A genetically engineered bacterial strain producing DL-alanine, a construction method therefor and an application thereof, which relate to the field of bioengineering. By enhancing a glycolytic pathway and introducing a thermostable alan...  
WO/2023/050716A1
Provided is weissella confusa WSG1 having the ability to assist digestion. The deposit number of the strain is CGMCC NO. 22697, and a nucleotide sequence of 16S rRNA is as shown in SEQ ID NO. 1. The strain can survive in the gastrointest...  
WO/2023/050513A1
Disclosed are a fungus LJD-6 capable of efficiently degrading benzo[a]pyrene and an application thereof. Aspergillus elsenburgensis LJD-6 was preserved in Guangdong Microbial Culture Collection Center (GDMCC) on August 31, 2021, with the...  
WO/2023/051077A1
Provided are a genetically engineered strain for producing polylactic acid and a method for producing polylactic acid. The method comprises: synthesizing a D-lactate dehydrogenase gene, a propionyl-CoA transferase gene and a polyhydroxya...  
WO/2023/049961A1
The present invention provides novel strains of Zopfiella sp. and variants thereof, particularly Zopfiella sp. NEM41, plants inoculated therewith, and biopolymers secreted therefrom. The present invention also relates to compositions com...  
WO/2023/053073A1
Described herein is a method of improving the inhibitory profile of Streptococcus salivarius comprising formulating the S. salivarius in a composition comprising an effective amount of a supplemental saccharide. Also described herein are...  
WO/2023/052927A1
Provided is a method for the production of single cell protein (SCP) comprising anaerobic fermentation of Clostridia bacterium on a fermentation medium comprising a gas, wherein said gas provides a source of energy and carbon for said ba...  
WO/2023/054973A1
Provided are a composition comprising an extract of an Epidermidibacterium keratini strain for improving the texture of the skin or alleviating the occurrence of dead skin, a fabric softener composition comprising same, and a preparation...  
WO/2023/053121A1
Methods and systems for pretreatment of organic waste prior to large-scale production of lactic acid from the organic waste are provided, which employ dried or partially-dried compositions of Bacillus coagulans spores. The methods and sy...  
WO/2023/053146A1
The present invention relates to bio-fungicides that inhibits Phytophthora infestans. More particularly, the present invention relates to novel strains of Bacillus spp. that can inhibit Phytophthora infestans. The present invention also ...  
WO/2023/055286A1
The present application discloses various bacterial strains, preferably Bacillus spp. (Deposition numbers DSM33837, DSM33838 and DSM33839) as well as the use of said bacterial strains individually or in combination in methods of fermenta...  
WO/2023/048198A1
The present application provides a method for culturing Lactobacillus plantarum, the method comprising culturing Lactobacillus plantarum in a culture medium containing molasses, yeast extract and sucrose at a temperature of 32 to 37°C.  
WO/2023/048334A1
The present invention provides a Lactobacillus plantarum) Probio 88 strain and an extract and a composition, each containing same. The strain, extract, and composition according to the present invention have the effects of suppressing SA...  
WO/2023/046966A1
The present invention relates to the biological control of vibriosis in aquatic animals such as molluscs, that are notably produced in aquaculture for human consumption. The present invention also relates to a particular bacterial strain...  
WO/2023/047070A1
The invention relates to the field of natural flavours used in the agri-food industry. More particularly, the invention relates to a genetically modified microorganism strain capable of producing larger amounts of volatile organic compou...  
WO/2023/048594A1
The invention relates to the field of purifying petroleum products, particularly diesel fuel, of particles greater than 4 μm. For this purpose, a biosorbent has been developed which contains an aqueous suspension of inactivated microorg...  
WO/2023/047005A1
The present invention relates to the bacterial strain Pseudomonas atacamensis BBB003 (CECT 30419), a microorganism of the Gram-negative group of bacteria, genus Pseudomonas, which improves plant production and stimulates the secondary me...  
WO/2023/039922A1
Provided are a mutant strain of carotenoid-producing yeast and an application of a mutation site thereof. Saccharomyces cerevisiae W2, deposited in the GuangDong Microbial Culture Collection Center, having the deposit number GDMCC No: 61...  
WO/2023/041040A1
A high temperature resistant mannanase mutant, comprising at least one mutation site among D49C/I/N, G58D/E/S, H90L, T99Y, K120Y, N124P, T130D/N/P/Q/R/S, Y132F, S136M, S140L/K, T148K, F206Y, A212N/S/P, L257F, S263R, D268A/E/G/P, G273P, S...  
WO/2023/041062A1
Pseudomonas and a use thereof. The preservation number of the pseudomonas is CGMCC No. 22583. The growth temperature of the pseudomonas is 37-45°C; under a medium-high temperature oil reservoir condition, the pseudomonas can be denature...  
WO/2023/040422A1
The use of one or more strains of Lactobacillus reuteri PLBK®1, Lactobacillus reuteri PLBK®2, Lactobacillus gasseri PLBK®3, Lactobacillus acidophilus PLBK®4 and Bifidobacterium lactis PLBK®5 and fermentation cultures or metabolites ...  
WO/2023/041425A1
The present invention concerns C. glutamicum strains expressing modified gluconate repressor proteins GntR1 and GntR2 and a method for the fermentative production of L-lysine using such C. glutamicum strains.  
WO/2023/043063A1
The present application relates to a novel microalgae strain with the efficacy of promoting plant growth and a use thereof. When cultured in the presence of fermentation exhaust gas, a novel Chlorella vulgaris CD02-3002 strain according ...  
WO/2023/041008A1
Provided are a Kosakonia oryzae HN05 strain and the use thereof. The strain can oxidize and degrade diquat under an anaerobic condition, and has the reduction activity of an anthraquinone compound. The strain can cooperate with AQDS to p...  
WO/2023/041574A1
The invention is in the field of bacterial strains isolated from the mammalian digestive tract and the use of such strains, and compositions comprising these strains, in the treatment of disease.  
WO/2023/040565A1
Provided are a glutamine synthetase mutant having glufosinate-ammonium resistance, a nucleic acid molecule and the use, which relate to the technical field of genetic engineering. The glutamine synthetase mutant can be obtained by means ...  
WO/2023/041203A1
The invention is in the field of bacterial strains isolated from the mammalian digestive tract and the use of such strains, and compositions comprising these strains, in the treatment of disease.  
WO/2023/039936A1
Provided are an expression cassette for expressing a gene containing an overlapping open reading frame in an insect cell, and the use thereof. The expression cassette contains, from 5' to 3', a promoter capable of driving transcription i...  
WO/2023/043111A1
The present invention pertains to: a novel microorganism; a lysate, a culture, and an extract thereof; and a use thereof for improving hair or scalp condition. A novel Paracoccus denitrificans strain according to an aspect has the effect...  
WO/2023/039645A1
The present invention relates to new strains of Enterococcus sp., in particular, inflammatory and non-inflammatory strains of Enterococcus sp., useful for bacterio therapy.  
WO/2023/039921A1
Provided are a composite microbial agent for degrading petroleum hydrocarbons, and a preparation method therefor and the use thereof. The composite microbial agent is composed of live Acinetobacter KJ-1 with the deposit number of CGMCC N...  
WO/2023/040426A1
Provided are a formula of probiotics and metabolites thereof for alleviating metabolic syndromes, and the use thereof. The formula comprises Lactobacillus reuteri PLBK®1, Lactobacillus reuteri PLBK®2, Lactobacillus gasseri PLBK ®3, La...  
WO/2023/035527A1
Provided is engineered Escherichia coli for producing olivetol and olivetolic acid. An Escherichia coli fabH gene is deleted and an olivetol synthase is expressed, thereby improving the yield of olivetol and olivetolic acid.  
WO/2023/035396A1
Provided are an olivetol synthetase variant and an engineered Escherichia coli expressing same for the production of olivetol and olivetolic acid. The engineered Escherichia coli is modified to express an olivetol synthetase variant whic...  
WO/2023/038418A1
The present invention relates to a bifidobacterium bifidum EPS DA-LAIM strain (KCTC 14638BP) for intestinal health, having the effect of promoting growth of lactobacillus, polysaccharides produced from same, and a composition comprising ...  
WO/2023/038258A1
The present invention relates to a Lactobacillus gasseri LM1065 strain (KCCM13018P), and a composition, for alleviating premenstrual syndrome, comprising same. The Lactobacillus gasseri LM1065 strain (KCCM13018P) according to one impleme...  
WO/2023/035357A1
Provided are a lipase mutant and an application thereof. Specifically, one or more mutations selected from A262H, A338V, V364I, A158P/V, and I159N are generated on the basis of an amino acid sequence as shown in SEQ ID NO: 1; compared wi...  

Matches 501 - 550 out of 54,864